Presentation is loading. Please wait.

Presentation is loading. Please wait.

Anna Björkenheim et al. JACEP 2017;j.jacep

Published byShannon Hall Modified over 5 years ago

Similar presentations

Presentation on theme: "Anna Björkenheim et al. JACEP 2017;j.jacep"— Presentation transcript:

1 Anna Björkenheim et al. JACEP 2017;j.jacep.2017.04.003
Scatterplot Comparing Changes in AF6 Sum Score and European Heart Rhythm Association Class Before and After Ablation (A) 6 months (r = 0.31, r2 = 0.10, p = 0.02), (B) 12 months (r = 0.32, r2 = 0.10, p = 0.03), and (C) 24 months (r = 0.22, r2 = 0.05, p = 0.12) after ablation. Negative values indicate improvement and positive values deterioration. Patients in the lower left quadrant show improvement and in the upper right quadrant worsening in both AF6 score and European Heart Rhythm Association (EHRA) class, while patients with discordant results are found in the upper left and lower right quadrants. Anna Björkenheim et al. JACEP 2017;j.jacep 2017 The Authors

Download ppt "Anna Björkenheim et al. JACEP 2017;j.jacep"

Similar presentations

CYB561 mutations. CYB561 mutations. The upper part shows the structure of the CYB561 gene, with the positions of the identified mutations indicated. Gray.

CYB561 mutations. CYB561 mutations. The upper part shows the structure of the CYB561 gene, with the positions of the identified mutations indicated. Gray.
CHA2DS2-VASc Scoring System General AF Treatment Guidance.

CHA2DS2-VASc Scoring System General AF Treatment Guidance.
Tom F. Brouwer et al. JACEP 2016;2:

Tom F. Brouwer et al. JACEP 2016;2:
MAGIC-AF Trial design: Patients with persistent atrial fibrillation (AF) and remaining in AF after pulmonary vein isolation alone were randomized to either.

MAGIC-AF Trial design: Patients with persistent atrial fibrillation (AF) and remaining in AF after pulmonary vein isolation alone were randomized to either.
Endothelial Dysfunction in Patients With Lone AF and AF Patients With Comorbidities Compared With That in Controls Comparisons are shown among control.

Endothelial Dysfunction in Patients With Lone AF and AF Patients With Comorbidities Compared With That in Controls Comparisons are shown among control.
Masatoshi Yamazaki et al. JACEP 2015;1:

Masatoshi Yamazaki et al. JACEP 2015;1:
Waddah Maskoun et al. JACEP 2016;2:

Waddah Maskoun et al. JACEP 2016;2:
Konstantinos C. Siontis et al. JACEP 2016;2:

Konstantinos C. Siontis et al. JACEP 2016;2:
Pablo Ávila et al. JACEP 2015;1:

Pablo Ávila et al. JACEP 2015;1:
Shadi Al Halabi et al. JACEP 2015;1:

Shadi Al Halabi et al. JACEP 2015;1:
Amir Jadidi et al. JACEP 2018;4:

Amir Jadidi et al. JACEP 2018;4:
Amir Jadidi et al. JACEP 2018;4:

Amir Jadidi et al. JACEP 2018;4:
Masatoshi Yamazaki et al. JACEP 2015;1:

Masatoshi Yamazaki et al. JACEP 2015;1:
Alexander Sedaghat et al. JACEP 2017;3:71-75

Alexander Sedaghat et al. JACEP 2017;3:71-75
Jose C. Pachon M. et al. JACEP 2015;1:

Jose C. Pachon M. et al. JACEP 2015;1:
Matrix used to calculate the kappa statistic.

Matrix used to calculate the kappa statistic.
Tom F. Brouwer et al. JACEP 2016;2:

Tom F. Brouwer et al. JACEP 2016;2:
Simon W. Rabkin et al. JACEP 2017;j.jacep

Simon W. Rabkin et al. JACEP 2017;j.jacep
Pablo B. Nery et al. JACEP 2016;2:

Pablo B. Nery et al. JACEP 2016;2:
(A) Frequency of synchronous diagnosis of primary tumour and BM according to primary tumour type (B) Frequency of patients with asymptomatic BM at first.

(A) Frequency of synchronous diagnosis of primary tumour and BM according to primary tumour type (B) Frequency of patients with asymptomatic BM at first.

Similar presentations

Ads by Google